Innovex International (INVX) Receives Buy Rating with $35 Target
Published on · Source: finance.yahoo.com

AI Summary
Summarized by AI from the source belowOn May 6, 2026, Citi initiated coverage of Innovex International, Inc. (INVX) with a Buy rating and a price target of $35. For Q1 2026, Innovex reported revenue of $239 million, reflecting a 1% decline year over year. The company expects Q2 revenue between $235 million and $245 million, along with adjusted EBITDA of $43 million to $48 million. CEO Adam Anderson stated that operational execution and new product launches contributed to stronger-than-expected results. Innovex also completed an acquisition during the quarter, enhancing its offshore market position.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Related News

DB Growth Momentum Targets for 2028 Gain Traction
Sep 25

Abeona Therapeutics stock Buy rating maintained by H.C. Wainwright
Sep 25

Ultragenyx Stock Rating Reiterated by H.C. Wainwright on FDA Approval
Sep 25

Surrozen Stock Target Raised on Wnt Pathway Validation Insight
Sep 25